logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5476.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5476.produseast1
World Malaria Day 2022 | Collections | MSF Science Portal
World Malaria Day 2022

World Malaria Day 2022

Collection Content

Journal Article
|
Research

Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger

Coldiron ME, Assao B, Guindo O, Sayinzoga-Makombe N, Koskalova A,  et al.
2021-10-24 • Malaria Journal
2021-10-24 • Malaria Journal
BACKGROUND
Malaria transmission is highly seasonal in Niger. Despite the introduction of seasonal malaria chemoprevention (SMC) in the Magaria District, malaria incidence remains hig...
Conference Material
|
Abstract

Revision of the epidemiological situation of malaria in Burundi and the potential implications for future control

Leclair C, Marien J, Sinzinkayo D, Abdelrahman A, Lampaert E,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
INTRODUCTION
In Burundi, malaria continues to be a major public health issue as the leading cause of health facility attendance, high levels of mortality and devastating malaria epid...
Conference Material
|
Slide Presentation

Feasibility of large-scale mass drug administration? for malaria in Angumu health zone, DRC

Sterk E, Newport T, Mahamat TA, Gitahi P, Mandagot JJ,  et al.
2021-05-19 • MSF Scientific Days International 2021: Research
2021-05-19 • MSF Scientific Days International 2021: Research
Journal Article
|
Research

Identification of main malaria vectors and their insecticide resistance profile in internally displaced and indigenous communities in Eastern Democratic Republic of the Congo (DRC)

Loonen JACM, Dery DB, Musaka BZ, Bandibabone JB, Bousema T,  et al.
2020-11-23 • Malaria Journal
2020-11-23 • Malaria Journal
BACKGROUND
Malaria remains a major public health concern in the Democratic Republic of the Congo (DRC) and its control is affected by recurrent conflicts. Médecins Sans Frontières (M...
Journal Article
|
Commentary

Needs and challenges in modelling malaria for emergency contexts

Boëte C, Guardiola M, Lasry E, Burza S, Moriana S,  et al.
2020-09-01 • Trends in Parasitology
2020-09-01 • Trends in Parasitology
While modelling is an essential component for an understanding of the epidemiology of malaria, and for designing better control measures, it rarely considers the particular contexts enco...
Conference Material
|
Slide Presentation

Use of population pharmacokinetics to assess adherence to amodiaquine used for seasonal malaria chemoprevention

Coldiron ME
2020-05-13 • MSF Scientific Days International 2020
2020-05-13 • MSF Scientific Days International 2020

See more collections

MSF logo
Diphtheria
No description available
The endTB project
The endTB project

The endTB project aims to find shorter, less toxic and more effective treatments for ‘multidrug-resistant TB’ (MDR-TB) through:

  • access to new drugs
  • two clinical trials
  • advocacy at national and global levels

Covering 18 countries, the project is a partnership between Partners In Health, Médecins Sans Frontières, Interactive Research & Development and financial partners Unitaid and the Transformational Investment Capacity (TIC) of MSF. This collection contains the final and intermediate results of the studies, advocacy reports, and study presentations. For more information about the endTB project, visit https://endtb.org/.

Combatting antibiotic resistance 2022
Combatting antibiotic resistance 2022
Resistance to antibiotics is a growing public health crisis, especially in countries with fragile health systems and in regions at war. The World Health Organization has estimated that antibiotic-resistant bacteria caused nearly 1.3 million deaths in 2019, a toll that will increase significantly in the coming years if effective action is not taken. To mark World Antimicrobial Awareness Week 2022 (18-24 November) we present a snapshot of MSF’s recent work on responding to this growing threat. Since many humanitarian settings lack laboratory capacity to diagnose these infections, MSF and partners have developed two new technologies with the potential to dramatically expand the availability of accurate diagnosis—allowing clinicians to then tailor antibiotic treatment accordingly. Other work from diverse contexts describes practices and challenges related to optimizing rational antibiotic use within health facilities and communities. Lastly, several studies characterize the patterns and prevalence of antibiotic resistance among MSF patients, from hospitalized neonates in Central African Republic to acute trauma patients in Haiti and Yemen.
View All Collections